MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6121-6130 Newer>
The Motley Fool
January 8, 2010
Brian Orelli
Heartburn Relieved ... for Now AstraZeneca settles its patent dispute with Teva. mark for My Articles 569 similar articles
The Motley Fool
January 8, 2010
Brian Orelli
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands. mark for My Articles 1332 similar articles
BusinessWeek
January 7, 2010
Catherine Arnst
Hospitals: Radical Cost Surgery A hospital that slashes costs - and delivers high-quality care as it innovates? Yes, it exists. mark for My Articles 567 similar articles
BusinessWeek
January 7, 2010
Capell & Doherty
What Novartis Sees in Eye Care Novartis CEO Dan Vasella's $50 billion bet on Alcon could help insulate it from the vagaries of the drug business. mark for My Articles 133 similar articles
The Motley Fool
January 7, 2010
Brian Orelli
Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered. mark for My Articles 1356 similar articles
The Motley Fool
January 7, 2010
Brian Orelli
Warning: Potential Anemic Growth Ahead Anemia-drug makers get more scrutiny from the FDA. mark for My Articles 956 similar articles
Chemistry World
January 6, 2010
Ned Stafford
UK libel laws threaten scientific debate A libel lawsuit brought by GE Healthcare has succeeded in silencing an eminent Danish radiologist who questioned the safety of one of the firm's drugs, but the firm is now being accused by some in the scientific community of trying to stifle legitimate scientific discussion. mark for My Articles 50 similar articles
The Motley Fool
January 6, 2010
Brian Orelli
Gilead Goes It Alone ... for Now Investors jump for joy as Gilead Sciences announces what on the surface sounds like rather inconsequential data. mark for My Articles 245 similar articles
The Motley Fool
January 5, 2010
Brian Orelli
A Deal Manufactured by Necessity Genzyme gets some help from a new friend. mark for My Articles 151 similar articles
The Motley Fool
January 5, 2010
Brian Orelli
Lilly's Effient: Cheap Enough, for Now In order to justify the use of Effient, Eli Lilly is touting a study published in today's Circulation demonstrating the cost effectiveness of Effient over Plavix. mark for My Articles 347 similar articles
<Older 6121-6130 Newer>    Return to current articles.